Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4)

(3)
Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4) image
ISBN-10:

0323227147

ISBN-13:

9780323227148

Author(s): Kumar MD, Anand
Edition: 1
Released: Oct 29, 2013
Publisher: Elsevier
Format: Hardcover, 0 pages
Related ISBN: 9781455775842

Description:

The second in a two-part series on Life-Threatening Infections. Article topics include: Biowarfare/Bioterrorism pathogens, Infections in neutropenics, Infections in AIDS, Influenza and endemic viral pneumonias, Resistant gram negative infections, Toxic Shock Syndrome, Fulminant viral myocarditis, and Overwhelming post-splenectomy infection.

Best prices to buy, sell, or rent ISBN 9780323227148




Frequently Asked Questions about Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4)

You can buy the Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $7.98 on Amazon and is available from 8 sellers at the moment.

If you’re interested in selling back the Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Life-Threatening Infections: Part 2, An Issue of Critical Care Clinic (Volume 29-4) (The Clinics: Internal Medicine, Volume 29-4) book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.